Rarity Bioscience in a a €6.5 million funding round led by Navigare Ventures, joined by existing shareholders Novalis Biotech and UU Invest
09 June 2024
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom